potentially a multiple of the current price, page-10

>If we get equal to or greater PFS than 12 weeks Id be pretty disappointed if we weren't at least $3 within 2 months of the announcement

I love your optimism Fly. Yes, the potential would be huge. But it is just that - potential. Be realistic. Even with FDA approval, IF we get US$500 million a year in sales at an optimistic 15% royalty with a good partner, that is only ~$80 million (AU$) a year before costs. Take out costs and tax and maybe we generate $40 million in NPAT. Add in $10 million a year for Fonda and ACL would conservatively be worth $500 million, or about $1.50 a share.

The market will pay more for upside, but that doesn't make it worth more.